Navigating One’s Bio-Pharma Career through 2023’s Turbulent Job Markets
Pharmaceutical Commerce
FEBRUARY 3, 2023
Jasmin Patel of a-Connect provides insight on how to navigate the ebbs and flows of employment.
Sat.Jan 28, 2023 - Fri.Feb 03, 2023
52 
J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries
Fierce Pharma
FEBRUARY 3, 2023
J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries mbayer Fri, 02/03/2023 - 09:29
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
GoodRx Illegally Sold Users’ Data to Google & Facebook, FTC Says
MedCity News
FEBRUARY 1, 2023
GoodRx failed to notify users that it sold their personal health information to Google, Facebook and other tech companies, the FTC claimed. The agency filed an order that prohibits GoodRx from sharing its users’ data with third parties for advertising purposes and requires the company to pay a $1.5 million penalty. GoodRx agreed to pay the settlement but did not admit to wrongdoing.
HIV vaccines suffer setbacks but new approaches could turn the tide
Pharmaceutical Technology
FEBRUARY 3, 2023
Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections. This marks the second time one of Janssen’s HIV vaccines failed after another showed disappointing results in the Phase IIb Imbokodo trial in August 2021.
Smart Walking Stick for Visually Impaired People
Medgadget
JANUARY 30, 2023
Researchers at the University of Colorado at Boulder have developed a smart walking stick that can assist blind or visually impaired people to navigate their environment, from grocery shopping to finding a seat in a busy café. The system employs cameras to visualize the environment and items within it, such as products in a supermarket, and uses AI to identify objects and provide guidance for the user.
Pfizer warns Comirnaty sales will plummet by nearly two-thirds in 2023. And Paxlovid won't fare much better
Fierce Pharma
JANUARY 31, 2023
Pfizer warns Comirnaty sales will plummet by nearly two-thirds in 2023.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
US FDA approves GSK’s Jesduvroq to treat anaemia of CKD
Pharmaceutical Technology
FEBRUARY 2, 2023
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline ’s (GSK) Jesduvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at least four months. Jesduvroq is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It is claimed to be the only HIF-PHI approved in the country that offers a new oral treatment option for adult patients on dialysis with anaemia of CKD.
Tyber Medical LLC Acquires ADSM-Synchro Medical
Legacy MEDSearch
FEBRUARY 2, 2023
Tyber Medical LLC has acquired 100 percent of the capital of ADSM-Synchro Medical, a French orthopedic medical device company, specializing in the development and distribution of implants dedicated to treating surgical forefoot pathologies. Founded in 2010, ADSM has become a market leader in the European medical device industry with products like the ToeGrip Classic, the first hammer toe implant of its kind developed with PEEK material.
Amid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro
Fierce Pharma
FEBRUARY 2, 2023
Amid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro fkansteiner Thu, 02/02/2023 - 11:20
I’m a GI Doctor. A Colon Cancer Screening Could Save Your Life.
MedCity News
JANUARY 29, 2023
A recent NEJM publication concluded that although colonoscopy is widely used as a dependable screening test to detect colorectal cancer, its overall effect on the risks of colorectal cancer death is potentially less clear than previously reported. The doubt sprouting from this study is misplaced, dangerous and will potentially lead to more deaths from this disease.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pfizer reports 30% operational growth in full-year 2022 revenues
Pharmaceutical Technology
FEBRUARY 1, 2023
Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. The revenues grew 2% operationally excluding Paxlovid and Comirnaty’s contributions. In the fourth quarter (Q4) of 2022, they increased 13% operationally to $24.3bn compared to $23.8bn in the same quarter last year. On an operational basis, the revenues rose by 5%, omitting contributions from Paxlovid and Comirnaty.
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Legacy MEDSearch
JANUARY 31, 2023
Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that the U.S. Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation system. The newly approved Axonics R20 neurostimulator is labeled for a functional life in the body of at least 20 years and reduces how frequently a patient needs to recharge their implanted device to just on
Amgen's Humira biosimilar Amjevita hits the market with two different list prices
Fierce Pharma
JANUARY 31, 2023
Amgen's Humira biosimilar Amjevita hits the market with two different list prices zbecker Tue, 01/31/2023 - 10:58
Why Telehealth Implementation Is Not Just a Project for IT
MedCity News
FEBRUARY 3, 2023
Telehealth implementation should be a joint responsibility of IT, administration, and providers. Otherwise, a lack of teamwork between departments leads to siloing and lots of passing the telemedicine “hot potato” among those who don’t have all the information.
How to Stay Competitive in the Evolving State of Martech
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
Magazine: CRISPR gene therapies cut through in 2023
Pharmaceutical Technology
FEBRUARY 2, 2023
If things go as per plan, in a few months, the US Food and Drug Administration (FDA) will deliberate on the first-of-its-kind CRISPR-based gene therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassemia. Having made significant advances in a relatively short period of time, CRISPR research is now edging closer to reaching the clinic , and this month’s cover story takes a look at the major players in this field and the big events that could break through this year.
Unlocking the promise of patent renewals
Clarivate
JANUARY 30, 2023
As patent filings grow at unprecedented rates, companies are beginning to realize the strategic importance of patent renewals, unlocking their ‘data power’ A new report from Clarivate , Global patent renewals trends , leans on enriched patent and IP case data paired with human expertise and technology to analyze patent filing activity. Through the report, law firms and in-house legal teams can gain a better understanding of maintenance behaviors to help unleash annuities’ strategic v
Menarini shows Big Pharma how it's done with first approval for oral SERD drug in breast cancer
Fierce Pharma
JANUARY 30, 2023
Menarini shows Big Pharma how it's done with first approval for oral SERD drug in breast cancer kdunleavy Mon, 01/30/2023 - 10:22
FDA Asks Gene Therapy Biotech to Run Clinical Trial That Might Be Impossible
MedCity News
FEBRUARY 1, 2023
Taysha Gene Therapies has encouraging data from an open-label, Phase 1/2 study in the rare disease giant axonal neuropathy. It might not be enough. The FDA recommended the biotech conduct a randomized and placebo-controlled study—a challenge in any ultra-rare disease.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Merck reports 2% increase in worldwide sales in Q4 2022
Pharmaceutical Technology
FEBRUARY 3, 2023
Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter. The company’s pharmaceutical sales recorded a 1% rise to $12.18bn compared to $12.03bn in the prior-year quarter. For the quarter, GAAP earnings per share (EPS) from continuing operations was $1.18, indicating a 22% decline from $1.5 in the same quarter last year.
RefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy; Cutting-edge Treatment Applicable for Early and Late-stage Cancers
Legacy MEDSearch
FEBRUARY 3, 2023
RefleXion Medical , a therapeutic oncology company, announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX biology-guided radiotherapy, a cutting-edge treatment applicable for early and late-stage cancers. The company will host a live-stream event featuring both its co-founder and CEO discussing the breakthrough significance of SCINTIX therapy for cancer treatment.
In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion
Fierce Pharma
JANUARY 31, 2023
In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion aliu Tue, 01/31/2023 - 10:37
With Livongo, did Zane Burke sell a lemon to Teladoc’s Jason Gorevic?
MedCity News
JANUARY 29, 2023
Was Livongo a good business? As Burke, now CEO of Quantum Health, touts its strength to investors ahead of a potential IPO, should the Livongo-Teladoc history give them pause?
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
What Role Does Healthcare SEO Play in a 2023 Marketing Strategy?
LEVO Health
JANUARY 31, 2023
As the healthcare industry continues to evolve, digital marketing strategies, such as search engine optimization (SEO), have become increasingly crucial for healthcare organizations. Search engine optimization sits at the heart of any successful healthcare marketing strategy. Therefore, it is essential to become familiar with the role SEO strategy plays in healthcare marketing and healthcare SEO best practices that should be employed in 2023 to create a successful digital marketing plan.
Zydus -Walk-In Interviews for Production/ Packing/ Warehouse/ QC On 29th Jan’ 2023
Pharma Pathway
JANUARY 28, 2023
Zydus -Walk-In Interviews for Production/ Packing/ Warehouse/ QC On 29th Jan’ 2023 Job Description Inviting Candidates for a walk-In Interview for Formulations Manufacturing plat (OSD), Matoda, Ahmedabad On 29th Jan’ 2023. The Interview will take place at Ahmedabad District. We are recruiting for Formulation Manufacturing Plant (OSD) at SEZ -1 (Matoda), Ahmedabad Departments: Production/ Packing/ Warehouse/ QC Term Employee: ITI/ Diploma Engineer/ Pharmacy With 1-4 years of experience Inte
Court rejects Johnson & Johnson's Texas two-step bankruptcy ploy for talc claims
Fierce Pharma
JANUARY 30, 2023
Court rejects Johnson & Johnson's Texas two-step bankruptcy ploy for talc claims kdunleavy Mon, 01/30/2023 - 16:24
What Health Plans Need To Know About QHPs Now That the ACA Is Here To Stay
MedCity News
JANUARY 29, 2023
Now that numerous calls for repeal and legal challenges brought against the ACA over the years have failed, health plans can finally invest confidently in this line of business.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Capture Videos of HCPs at ASCO
Storyvine
FEBRUARY 2, 2023
ASCO is a great opportunity to reconnect with colleagues, show off your brand and discover what’s new in cutting edge oncology research. Storyvine wants to help you make the most of it. We all know how busy doctors can be, and here's your chance to not only meet them in person, but to film them talking about their expertise, and the latest research and learnings.
France gets new sterile liquid drug manufacturing facility
European Pharmaceutical Review
FEBRUARY 3, 2023
Switzerland-based contract development and manufacturing organisation (CDMO) CARBOGEN AMCIS has opened a new facility in France, dedicated to the custom development and production of sterile injectable drug products. The facility forms two new fully-automated production lines for liquid and freeze-dried drugs, including highly potent compounds and advanced therapies such as antibody drug conjugates (ADCs).
Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3
Fierce Pharma
JANUARY 31, 2023
Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3 ntaylor Tue, 01/31/2023 - 06:26
Healthcare Spent $18B More on Administrative Tasks in 2022 Than Year Prior
MedCity News
FEBRUARY 3, 2023
The U.S. healthcare system spent $60 billion on administrative tasks last year, which is about $18 billion more than it spent in 2021, according to a new report. There are a couple reasons for this — the workforce shortage and Americans’ increased utilization of healthcare services.
ABM Evolution: How Top Marketers Are Using Account-Based Strategies
Advertiser: ZoomInfo
In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.
Let's personalize your content